Sage Therapeutics

-$3.78 (-8.58%) Today
$0.00 (0.00%) As of 9:51 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SAGE and other ETFs, options, and stocks.

About SAGE

SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders.

CEO
Barry E. Greene
Employees
298
Headquarters
Cambridge, Massachusetts
Founded
2010

SAGE Key Statistics

Market Cap
2.37B
Price-Earnings Ratio
3.47
Dividend Yield
—
Average Volume
484.41K
High Today
$44.68
Low Today
$40.10
Open Price
$44.39
Volume
1.79M
52 Week High
$98.39
52 Week Low
$39.77

SAGE Earnings

-$3.14
$3.97
$11.08
$18.19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure